SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-020531
Filing Date
2020-05-01
Accepted
2020-05-01 16:49:53
Documents
5
Period of Report
2020-06-11
Effectiveness Date
2020-05-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A cbio-def14a_20200611.htm DEF 14A 701708
2 GRAPHIC gyp2linnhwe2000001.jpg GRAPHIC 2166
3 GRAPHIC gyp2linnhwe2000002.jpg GRAPHIC 2166
4 GRAPHIC gyp2linnhwe2000003.jpg GRAPHIC 87216
5 GRAPHIC gyp2linnhwe2000004.jpg GRAPHIC 51612
  Complete submission text file 0001564590-20-020531.txt   900514
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51173 | Film No.: 20841535
SIC: 2834 Pharmaceutical Preparations